Chemohormonal Therapy vs. Hormonal Therapy for Hormone-sensitive - Results from #3010

REVIEW UroToday

SHARE

Media

Search

GayBiProstate Study: Expanding Quality of Life and Understanding Sexual Function Post Treatment - Bernard Lee Details Dr Bernard Lee shares the background and details of the GayBiProstate Study with Dr. Alicia Morgans. He explains the GayBiProstate study was developed for a patient population which is historically under studied when it comes to quality of life. The study focuses on sexual function of gay and bisexual patients ages 18-75 with a history of prostate cancer who have received prostate cancer treatment...
Treatment Options for Bladder Cancer: Bringing Life to Years of Sparse Options - Guru Sonpavde Details (Length of Discussion - 9 min) Dr. Alicia Morgans discusses with Dr. Guru Sonpavde the advances in the field of bladder cancer in regards to immunotherapy treatment approaches and recent ongoing clinical trials. Dr. Morgans refers to these treatment options and new studies as bringing a freshness to a desert like climate which has been bladder cancer treatment over the past several decades. Dr. So...
UPWARD Study - Seizure Rates in Enzalutamide-Treated Men with mCRPC - Susan Slovin Details (Length of presentation: 17 min) Alicia Morgans, MD discusses the UPWARD Study with Susan Slovin, MD, PhD. A study Dr. Slovin was a part of conducting to answer the question “Are seizure rates affected by treatment with enzalutamide in patients with metastatic castration-resistant prostate cancer who have seizure risk factors?” Dr. Slovin discusses with Dr. Morgans the reasons for conducting the U...
News Update: Apalutamide as a Treatment for Non-Metastatic Castration-Resistant Prostate Cancer - Thomas Keane Details (Length of Update: 4 min) As we start a new year, Dr. Thomas Keane provides an update on exciting news in the area of non-metastatic castration-resistant prostate cancer with the FDA granting priority review for apalutamide as a treatment for non-metastatic castration-resistant prostate cancer. Currently, there are no FDA-approved treatments for patients with non-metastatic CRPC. Watch Video from...
The State of BPS/IC: "The Emperor Has No Clothes" - Christopher Payne Details Christopher Payne presents, "The Emperor Has No Clothes" and the current state of bladder pain syndrome and interstitial cystitis. Biography: Christopher K. Payne, MD. Emeritus Professor of Urology, Stanford University Medical School Co-Founder, Vista Urology & Pelvic Pain Partners Dr. Payne is nationally recognized as a leader on issues in female urology having served on NIH advisory/oversight pa...
Enhanced Recovery After Surgery (ERAS) Radical Cystectomy and Urinary Diversion- Ashish Kamat Details Ashish Kamat, MD presents: Enhanced Recovery After Surgery (ERAS) Radical Cystectomy and Urinary Diversion. This video lectures discusses the background, framework, importance of GI recovery and improvements of quality of life with ERAS. Dr. Kamat also emphasizes the importance of recognizing different readmission factors and appropriate follow up procedures. For reference, PDF version of slides B...
TUEPA-video_BTA Details
Axumin™ (Fluciclovine F 18) Injection for PET Imaging of Recurrent Prostate Cancer - Phillip Koo Details In this 5 for 5 Hot Topics, Phillip Koo, MD. presents the clinical background of Axumin™ (Fluciclovine F 18) Injection for PET Imaging of Recurrent Prostate Cancer, the first FDA-approved F18 PET Imaging Agent indicated in for use in patients with suspected recurrent prostate cancer. Dr. Koo discusses its use for men with suspected prostate cancer recurrence based on elevated PSA levels following...
Characteristics of Ideal Ureteral Stents - Monaj Monga Details Ureteral stents Manoj Monga, MD discusses the characteristics of an ideal ureteral stent. A ureteral stent is generally chosen to help relieve urinary tract obstruction because it is less invasive and has a lower risk of bleeding compared with placement of a percutaneous nephrostomy tube. Related Content: AUA 2019: Stent Duration and Increased Pain in the Hours After Ureteral Stent Removal